Nectar Lifesciences Ltd - 532649 - Disclosure Of Related Party Transactions
Pursuant to Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed the disclosure on Related Party Transactions of Nectar Lifesciences Limited on a consolidated basis for year ended on March 31, 2021. Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are furnishing herewith newspaper copy of Publication of Financial Results of the Company for the quarter and financial year ended on March 31, 2021, which have been published in the following newspapers: 1. Business Standard (English-all editions) dated 24.07.2021. 2. Desh Sewak (Punjabi) dated 24.07.2021. Nectar Lifesciences Ltd - 532649 - Sale Of Non Core Assets/ Core Assets Which Are Unproductive/ Less Productive
The Board of Directors in their meeting held on July 23, 2021 have in-principal approved the sale of Non Core Assets/ Core Assets which are unproductive/ less productive. The proceeds from sales of above assets will be used for repayment of Bank Loans. Nectar Lifesciences Ltd - 532649 - Appointment of Company Secretary and Compliance Officer
This is to inform you that the Board of Directors of the Company in their meeting held on July 23, 2021 have appointed Ms. Anubha (ACS 47868) as a Company Secretary & Compliance Officer of the Company with effect from August 01, 2021. NECTAR LIFESCIENCES LTD. - 532649 - Intimation Of Book Closure For AGM To Be Held On September 21, 2021
Register of Members and Share Transfer Books will be closed from September 15, 2021 to September 21, 2021 (Both days inclusive) for the purpose of AGM. Accordingly the cut-off date, to ascertain the eligibility of members for remote e-voting and polling/ e-voting at AGM, is September 14, 2021 i.e. the date prior to the commencement of book closure. NECTAR LIFESCIENCES LTD. - 532649 - Annual General Meeting (AGM) To Be Held On September 21, 2021
AGM and related matters as per attached letter. Nectar Lifesciences Ltd - 532649 - Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2021 And Outcome Of Board Meeting
Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2021 and Outcome of Board Meeting as per attached letter NECTAR LIFESCIENCES LTD. - 532649 - Board Meeting Intimation for Financial Results And AGM
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2021 ,inter alia, to consider and approve We wish to inform you that meeting of Board of Directors of the company will be held on July 23, 2021 to consider and approve, inter alia amongst items: 1. The Audited Financial Results for the Financial Year 2020-21, Financial Statements of the Company for the Financial Year 2020-21 and matters related thereto. 2. To Convene the Annual General Meeting of Members of the Company for the Financial Year 2020-21 and matters related thereto. 3. To fix Book Closure dates for the purpose of Annual General Meeting. Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are furnishing herewith newspaper Publication in respect of transfer of Equity Shares of the Company against which dividend remain unpaid/unclaimed for 7 conservative years, to Investor Education and Protection Fund (IEPF) pursuant to Rule 6 of the IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, which have been published in the following newspapers: 1. Business Standard (English-all editions) dated 12.07.2021. 2. Desh Sewak (Punjabi) dated 12.07.2021.